Hepatitis E: Scale of the problem in Spain;Hepatitis E: Dimensión del problema en España

Gastroenterologia y Hepatologia

Volumn 35, Issue 10, 2012, Pages 719-724

  Riveiro Barciela, Mar ^a   Rodríguez Frías, Francisco ^a   Buti, María ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Epidemiology; Hepatitis E; Spain

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; HEPATITIS E; HUMAN; PREVALENCE; RISK FACTOR; SPAIN; SWINE;

ANIMAL HUSBANDRY; ANIMALS; ANTIBODIES, VIRAL; BLOOD TRANSFUSION; DISEASE OUTBREAKS; FOOD CONTAMINATION; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER CIRRHOSIS; OCCUPATIONAL DISEASES; PREVALENCE; RISK FACTORS; SPAIN; SWINE; SWINE DISEASES; TRAVEL; WATER POLLUTION;

EID: 84870255980     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2012.03.003     Document Type: Article

References (52)

1. WHO. Viral Hepatitis Statement A62/22. [consultado 16/4/2009]. Disponible en: . http://apps.who.int/gb/ebwha/pdf_files/A62/A62_22-en.pdf.
2. Purcell R.H., Emerson S.U. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008, 48:494-503.
3. Vishwanathan R. Infectious hepatitis in Delhi (1955-56), a critical study: epidemiology. Indian J Med Res 1957, 45:49-58.
4. Balayan M.S., Andjaparidze A.G., Savinskaya S.S., Ketiladze E.S., Braginsky D.M., Savinov A.P., et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983, 20:23-31.
5. Pavio N., Meng X.J., Renou C. Zoonotic hepatitis: animal reservoirs and emerging risk. Vet Res 2010, 41:46.
6. Kamar N., Mansuy J.M., Cointault O., Selves J., Abravanel F., Danjoux M., et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008, 8:1744-1748.
7. Gerolami R., Moal V., Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008, 358:859-860.
8. Mateos M.L., Molina A., Ta T.H., Moreira V., Milicua J.M., Bárcena R. Hepatitis aguda E en Madrid: descripción de 18 casos. A, Ta TH, Moreira V, Milicua JM, Bárcena R. Gastroenterol Hepatol 2006, 29:397-400.
9. Buti M., Clemente-Casares P., Jardi R., Formiga-Cruz M., Schaper M., Valdes A., Rodriguez-Frias F., Esteban R., Girones R. Sporadic cases of acute autochthonous hepatitis E in Spain. J Hepatol 2004, 41:126-131.
10. Sánchez M.A., Moreno M.E., García Avello A., Mateos M.L. Dos nuevos casos de hepatitis E autóctonos. Enferm Infecc Microbiol Clin 2002, 20:138.
11. Romero Gómez M., Suárez García E., Vargas J., Castro Fernández M. Un caso de hepatitis aguda E en Sevilla. Gastroenterol Hepatol 1997, 20:217-218.
12. Moreno García M., Fernández González F., Portús de Marco M.V., Mera Pérez P. Hepatitis aguda E en España. Med Clin (Barc) 1995, 105:716.
13. Suárez González A., Solís Sánchez G., Otero Guerra L., Viejo De La Guerra G., Alvarez Navascués C., García López R. Prevalence of immunity to hepatitis viruses in pregnant women from the health area of Gijón (Spain). Gastroenterol Hepatol 2004, 27:347-352.
14. Buti M., Plans P., Domínguez A., Jardi R., Rodriguez-Frias F., Esteban R., et al. Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol 2008, 15:732-734.
15. Galiana C., Fernández-Barredo S., Pérez-Gracia M.T. Prevalence of hepatitis E virus (HEV) and risk factors in pig workers and blood donors. Enferm Infecc Microbiol Clin 2010, 28:602-607.
16. Xing L., Li T.C., Mayakaki N., Simon M.N., Wall J.S., Moore M., et al. Structure of hepatitis E virion-sized particle reveals an RNA-dopendent viral assembly pathway. J Biol Chem 2010, 285:33175-33183.
17. Chauhan A., Jameel S., Dilawari J.B., Chawla Y.K., Kaur U., Ganguly N.K. Hepatitis E virus transmission to a volunteer. Lancet 1993, 341:149-150.
18. Khudyakov Y. Kamili S.Serological dianostics of hepatitis E virus infection. Virus Res 2011, 161:84-92.
19. Aggarwal R. Clinical presentation of hepatitis E. Virus Res 2011, 161:15-22.
20. Bhatia V., Singhal A., Panda S.K. Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse?. Hepatology 2008, 48:1577-1585.
21. Khuroo M.S., Kamili Jameel S. Vertical transmisión of hepatitis E virus. Lancet 1995, 345:1025-1026.
22. Erker J.C., Desai S.M., Schlauder G.G., Dawson G.J., Mushahwar I.K. A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J Gen Virol 1999, 80:681-690.
23. Meng X.J., Halbur P.G., Shapiro M.S., Shapiro M.S., Govindarajan S., Bruna J.D., et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998, 72:9714-9721.
24. Bihl F., Negro F. Hepatitis E virus: a zoonosis adapting to humans. J Antimicrob Chemother 2010, 65:817-821.
25. Aggarwal R., Naik S. Epidemiology of hepatitis E: Current status. J Gastroentgerol Hepatol 2009, 24:1484-1493.
26. Fogeda M., Avellón A., Echevarria J.M. Prevalence of specific antibody to hepatitis E vírus in the general population of the comunity of Madrid, Spain. J Med Virol 2012, 84:71-74.
27. Galiana C., Fernández-Barredo S., García A., Gómez M.T., Pérez-Gracia M.T. Occupational exposure to hepatitis E virus (HEV) in swine workers. Am J Trop Med Hyg 2008, 78:1012-1015.
28. Rodriguez-Manzano J., Miagostovich M., Hundesa A., Clemente-Casares P., Carratala A., Buti M., et al. Analysis of the evolution in the circulation of HAV and HEV in eastern Spain by testing urban sewage samples. J Water Health 2010, 8:346-354.
29. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
30. Le Coutre P., Meisel H., Hofmann J., Röcken C., Vuong G.L., Neuburger S., et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58:699-702.
31. Hamid S., Atiq M., Shehzad F., Yasmeen A., Nissa T., Salam A., et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002, 36:474-478.
32. Gerolami R., Moal V., Picard C., Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009, 50:622-624.
33. Kamar Garrousgte C., Haagsma E.B., Garrigue V., Pischke S., Chauvert C., Dumortier J., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
34. Buti M., Cabrera C., Jardi R., Castells L., Esteban R. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?. Liver Transpl 2010, 16:106-107.
35. Montes Martínez I., Agulla Budiño A. Prevalence of antibodies against hepatitis A, B, C and E viruses in the rural child population in Northern Extremadura. An Esp Pediatr 1996, 45:133-136.
36. Lindemann M.L., Gabilondo G., Romero B., De la Maza O.M., Pérez-Gracia M.T. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. J Med Virol 2010, 82:1666-1668.
37. Buti M., Domínguez A., Plans P., Jardí R., Rodríguez-Frias F., Gironés R., Esteban R., Salleras L., Plasencia A. Infrequent detection of hepatitis E virus RNA in pregnant women with hepatitis E virus antibodies in Spain. Live Int 2010, 30:1549-1551.
38. Jardi R., Crespo M., Homs M., Van den Eynde E., Girones R., Rodriguez-J, et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV-Medicine 2012, x. 10.1111/j.1468-1293.2011.00985.
39. Madejón A., Vispo E., Bottecchia M., Sánchez-Carrillo M., García-Samaniego J., Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009, 16:895-896.
40. Rivera M., Mateos M.L., Teruel J.L., Marcén R., Ortuño J. Hepatitis E virus markers in a peritoneal dialysis population. Perit Dial Int 2000, 20:576-577.
41. Mateos M.L., Teruel J.L., Sierra M.P., Gazapo E. High prevalence of hepatitis E virus antibodies in Spanish hemodialysis patients. Nephron 1997, 76:231-232.
42. Tarrago D., López-Vélez R., Turrientes C., Baquero F., Mateos M.L. Prevalence of hepatitis E antibodies in immigrants from developing countries. Eur J Clin Microbiol Infect Dis 2000, 19:309-311.
43. Bernal M.C., Leyva A., Garcia F., Galan I., Piedrola G., Heyermann H., Maroto M.C. Seroepidemiological study of hepatitis E virus in different population groups. Eur J Clin Microbiol Infect Dis 1995, 14:954-958.
44. Buti M., Jardí R., Cotrina M., Rodríguez-Frías F., Troonen H., Viladomiu L., et al. Hepatitis E virus infection in acute hepatitis in Spain. J Virol Methods 1995, 55:49-54.
45. Pina S., Buti M., Cotrina M., Piella J., Girones R. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J Hepatol 2000, 33:826-833.
46. Buti M., Jardi R., Rodriguez-Frias F., Quer J., Esteban R., Guardia J. Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E viruses. J Hepatol 1994, 20:589-592.
47. Echevarría JM, Fogeda M, Avellón A. Diagnosis of acute hepatitis E by antibody and molecular testing: a study on 277 suspected cases. J Clin Virol. 2011;50:69-71.
48. Fogeda M., De Ory F., Avellón A., Echevarría J.M. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J Clin Virol 2009, 45:259-261.
49. Quiroga J.A., Cotonat T., Castillo I., Carreño V. Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay. J Med Virol 1996, 50:16-19.
50. Pérez-Gracia M.T., García-Valdivia M.S., Galán F., Rodríguez-Iglesias M.A. Detection of hepatitis E virus in patients sera in southern Spain. Acta Virol 2004, 48:197-200.
51. Jardi R., Buti M., Rodríguez-Frias F., Hepatitis Esteban R. E infection in acute sporadic hepatitis in Spain. Lancet 1993, 341:1355-1356.
52. Mateos M.L., Camarero C., Lasa E., Teruel J.L., Mir N., Baquero F. Hepatitis E virus: relevance in blood donors and risk groups. Vox Sang 1999, 76:78-80.